These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 8895669)
21. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572 [TBL] [Abstract][Full Text] [Related]
22. [Significance of MMP-9 and TIMP-1 production during liver metastasis in colorectal cancer]. Ogata Y; Ookita A; Kakegawa T Nihon Rinsho; 1995 Jul; 53(7):1811-5. PubMed ID: 7630024 [TBL] [Abstract][Full Text] [Related]
23. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106 [TBL] [Abstract][Full Text] [Related]
24. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines. Wang M; Fudge K; Rhim JS; Stearns ME Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794 [TBL] [Abstract][Full Text] [Related]
25. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Nuovo GJ; MacConnell PB; Simsir A; Valea F; French DL Cancer Res; 1995 Jan; 55(2):267-75. PubMed ID: 7812956 [TBL] [Abstract][Full Text] [Related]
26. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer. Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357 [TBL] [Abstract][Full Text] [Related]
28. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Urbanski SJ; Edwards DR; Hershfield N; Huchcroft SA; Shaffer E; Sutherland L; Kossakowska AE Diagn Mol Pathol; 1993 Jun; 2(2):81-9. PubMed ID: 8269281 [TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Tamarina NA; McMillan WD; Shively VP; Pearce WH Surgery; 1997 Aug; 122(2):264-71; discussion 271-2. PubMed ID: 9288131 [TBL] [Abstract][Full Text] [Related]
30. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis. Gomez DE; De Lorenzo MS; Alonso DF; Andrade ZA Am J Trop Med Hyg; 1999 Jul; 61(1):9-13. PubMed ID: 10432047 [TBL] [Abstract][Full Text] [Related]
31. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone. Bord S; Horner A; Hembry RM; Reynolds JJ; Compston JE J Anat; 1997 Jul; 191 ( Pt 1)(Pt 1):39-48. PubMed ID: 9279657 [TBL] [Abstract][Full Text] [Related]
32. Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas. Lindsay CK; Thorgeirsson UP Clin Exp Metastasis; 1995 Sep; 13(5):381-8. PubMed ID: 7641422 [TBL] [Abstract][Full Text] [Related]
33. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153 [TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
35. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Onisto M; Garbisa S; Caenazzo C; Freda MP; Di Francesco C; Nitti D; Liotta LA; Stetler-Stevenson WG Diagn Mol Pathol; 1993 Jun; 2(2):74-80. PubMed ID: 8269280 [TBL] [Abstract][Full Text] [Related]
36. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524 [TBL] [Abstract][Full Text] [Related]
37. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071 [TBL] [Abstract][Full Text] [Related]
38. 72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection. Mellanen L; Salo T; Ingman T; Konttinen YT; Lähdevirta J; Sorsa T Acta Odontol Scand; 1998 Jun; 56(3):135-42. PubMed ID: 9688221 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Arii S; Mise M; Harada T; Furutani M; Ishigami S; Niwano M; Mizumoto M; Fukumoto M; Imamura M Hepatology; 1996 Aug; 24(2):316-22. PubMed ID: 8690399 [TBL] [Abstract][Full Text] [Related]
40. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]